Catheterization News and Research

RSS

Experts to discuss current treatments for children with heart disease at Cardiology 2012

An international group of almost 1000 medical experts gathers this week to discuss the most current treatments for children with heart disease. Affecting about a million children born each year throughout the world, congenital heart disease is the most common birth defect. In its severe forms, it is also the leading cause of death from birth defects in infants.

23 Feb 2012

U-M Cardiovascular Center now offers Edwards aortic valve replacement

As the population ages, more Americans will be susceptible to aortic stenosis, but not all patients can tolerate surgery to treat it. Select U.S. hospitals are now performing minimally invasive procedures called transcatheter aortic valve replacement, or TAVR, to replace a patient's diseased aortic valve without heart bypass or open heart surgery.

From Medtronic 23 Feb 2012

FDA approves Medtronic's Resolute Integrity DES to treat CAD

Advancing the clinical practice of interventional cardiovascular medicine, Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity Drug-Eluting Stent (DES) for the treatment of coronary artery disease.

From Medtronic 17 Feb 2012

Second chance may be the last chance for heart attack patients

After he failed to heed the first big warning about his heart, John Magri was lucky to survive the second.

15 Feb 2012

How 'observation care' status can drive up patients' hospital bills

News outlets report that this kind of status is leading some Medicare beneficiaries to be surprised by the size of hospital bills because, ultimately, the services they received were not classified as inpatient care.

7 Feb 2012

CRT2012 conference to discuss PCI procedures using CorPath 200 System

Corindus Vascular Robotics, a leading developer of precision vascular robotics, today announced that Giora Weisz, M.D., Director of Clinical Cardiovascular Research at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center and Associate Professor of medicine at Columbia University College of Physicians and Surgeons, New York, N.Y. will present his personal experience using the CorPath 200 System as part of the CorPath PRECISE Trial during a scientific presentation "Cath Lab of the Future: Robotics" at the Cardiovascular Research Technologies' annual meeting, CRT2012.

7 Feb 2012

Exposure to iodinated contrast media may increase risk of hyperthyroidism

Exposure to iodinated contrast media during imaging procedures is associated with changes in thyroid function, and increased risk of developing hyperthyroidism, according to a report in the January 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

24 Jan 2012

PLC Systems initiates enrollment in RenalGuard pivotal trial for CIN

PLC Systems Inc., a company focused on innovative medical device technologies, announced the successful enrollment of the first patient in the CIN-RG trial, the company's pivotal trial to study the efficacy of its RenalGuard Therapy and RenalGuard System in the prevention of Contrast-Induced Nephropathy.

24 Jan 2012

TCRH forms new joint venture with Duke LifePoint

Twin County Regional Healthcare (TCRH) has entered into a new agreement that will secure the hospital's position as a trusted provider of quality healthcare services for years to come. The TCRH Board of Directors and Duke LifePoint Healthcare today announced they have signed a definitive agreement to jointly own and operate Twin County Regional Healthcare and its affiliated assets.

20 Jan 2012

New AACN Practice Alert on catheter-associated urinary tract infections

Urinary tract infections account for nearly 40 percent of hospital-acquired infections in acute care hospitals, triggering increased hospital costs and higher patient morbidity and mortality rates. Compounding the toll of these infections, Medicaid, Medicare and many other payers no longer reimburse costs related to treatment because of their presumed preventability.

19 Jan 2012

Scottsdale Healthcare is first in Arizona to perform TAVR procedure

Scottsdale Healthcare Osborn Medical Center is the first hospital in Arizona to perform a new nonsurgical heart valve replacement procedure, the Transcatheter Aortic Valve Replacement (TAVR). TAVR valves are inserted via a catheter through the femoral artery, without requiring open heart surgery.

6 Jan 2012

Treatment for acute urinary retention due to BPH varies among countries

Men who experience a sudden inability to pass urine because of a non-cancerous enlarged prostate are hospitalised and treated differently depending on where they live, according to an international study published online by the urology journal BJUI.

28 Nov 2011

HRR1 after 6MW test is a strong predictor of clinical worsening in IPAH patients

Heart rate recovery at one minute after a six-minute walking distance (6MWD) test is highly predictive of clinical worsening and time to clinical worsening in patients with idiopathic pulmonary arterial hypertension (IPAH), according to a new study.

19 Nov 2011

New CAD test associated with higher rates of cardiac procedures, health-care spending

A new, noninvasive diagnostic test for coronary artery disease is associated with a higher rate of subsequent invasive cardiac procedures and higher health-care spending. That's according to an observational study of Medicare recipients conducted by researchers at the Stanford University School of Medicine.

16 Nov 2011

Atherosclerotic plaques spread downstream in coronary arteries

In human coronary arteries, atherosclerotic plaques tend to spread downstream because of the changes in blood flow patterns the plaque causes, researchers have found.

16 Nov 2011

InfraReDx launches enhanced version of LipiScan IVUS Coronary Imaging System

InfraReDx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery and other vascular diseases, today announced the launch of its TVC Imaging System, an enhanced version of the LipiScan IVUS Coronary Imaging System.

7 Nov 2011

Riverview to participate in Atlantic C-PORT-E Elective Angioplasty trial

In May 2009, Riverview Medical Center became part of a research study sponsored by Johns Hopkins University called the Atlantic C-PORT-E Elective Angioplasty trial. Riverview was selected to participate in this research study for its high level of experience and outstanding cardiovascular services.

4 Nov 2011

UCSD experts use hybrid OR to perform first-ever coronary revascularization procedure

UC San Diego Sulpizio Cardiovascular Center experts have performed San Diego's first-ever coronary revascularization procedure using a hybrid operating room, the only facility of its kind in the region. The state-of-the-art operating room allows patients to be treated in one place at one time without having to schedule multiple procedures.

4 Nov 2011

Gender not an independent predictor of mortality post-PCI

New research shows that women undergoing percutaneous coronary intervention (PCI), also known as angioplasty, exhibit more co-morbidities and cardiovascular risk factors than men. Risk-adjusted analyses have now indicated that, in the contemporary era, gender is not an independent mortality predictor following PCI according to the study now available in Catheterization and Cardiovascular Interventions, a journal published by Wiley-Blackwell on behalf of The Society for Cardiovascular Angiography and Interventions.

1 Nov 2011

Scripps researcher receives U-M's Eric J. Topol Professorship in Cardiovascular Medicine

The University of Michigan Medical School today announced the establishment of the Eric J. Topol Professorship in Cardiovascular Medicine. A world-renowned cardiologist, Dr. Topol is currently chief academic officer at Scripps Health and a senior cardiologist practitioner at Scripps Clinic.

27 Oct 2011